Skip to Main Content

Paper Details

A phase II trial of rebeccamycin analogue (NSC #655649) in children with solid tumors: a Children's Oncology Group study.
Pediatric Blood and Cancer
18
2008
CNS and non-CNS solid tumors, Ewing's sarcoma, NSC, NSC #655649, Rebeccamycin, amylase, children, glycosyl-dichloro-indolocarbazole, hepatotoxicity, lipase, medulloblastoma, myelosuppression, neuroblastoma, pancreatitis, patient, patients, pediatric tumor cell lines, rebeccamycin, relapsed and refractory cancer, rhabdomyosarcoma, solid and CNS tumors, solid tumors, topoisomerase, tumor

Datasets